GENIL GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Stock
Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş., sağlık ürünleri ve ilaçların toptan ticaretini yapan bir şirkettir.
| Period | Revenue | EBITDA | Net Income |
|---|---|---|---|
| 2026 Q1 | 6.6B | 1.0B | 375.1M |
| 2025 Q4 | 4.8B | 585.2M | 150.6M |
| 2025 Q3 | 6.0B | 609.5M | 247.1M |
| 2025 Q2 | 4.5B | 393.3M | 97.0M |
| 2025 Q1 | 3.9B | 533.0M | 319.8M |
| 2024 Q4 | 3.9B | 301.1M | 43.6M |
| 2024 Q3 | 4.4B | 403.3M | 111.2M |
| 2024 Q2 | 3.4B | 232.7M | -167.9M |
| Period | P/E (TTM) | TTM Net Income | E/P Quarterly | E/P Annual (TTM) |
|---|---|---|---|---|
| 2026 Q1 | 55.4 | 869.8M TRY | 0.0078 | 0.0181 |
| 2025 Q4 | 73.3 | 814.4M TRY | 0.0025 | 0.0136 |
| 2025 Q3 | 78.4 | 707.5M TRY | 0.0045 | 0.0128 |
| 2025 Q2 | 80.2 | 571.7M TRY | 0.0021 | 0.0125 |
| 2025 Q1 | 132.5 | 306.8M TRY | 0.0079 | 0.0075 |
| 2024 Q4 | 241.6 | 148.7M TRY | 0.0012 | 0.0041 |
| 2024 Q3 | — | -27.1M TRY | 0.0041 | -0.0010 |
| 2024 Q2 | 112.0 | 178.3M TRY | -0.0084 | 0.0089 |
| Period | Net Margin | Gross Margin | ROE | ROA | Debt/Equity | Rev. Growth (YoY) |
|---|---|---|---|---|---|---|
| 2026 Q1 | 5.7% | 29.5% | 12.8% | 6.7% | 0.37 | +71.7% |
| 2025 Q4 | 3.1% | 22.4% | — | 3.1% | — | +24.7% |
| 2025 Q3 | 4.1% | 19.5% | 10.1% | 5.7% | 0.20 | +37.2% |
| 2025 Q2 | 2.1% | 20.9% | 4.3% | 2.4% | 0.17 | +32.4% |
| 2025 Q1 | 8.3% | 21.5% | 15.3% | 9% | 0.19 | +24.5% |
| 2024 Q4 | 1.1% | 18.6% | 2.4% | 1.4% | 0.11 | +3.7% |
| 2024 Q3 | 2.6% | 19.6% | 6.9% | 4.4% | 0.21 | +85% |
| 2024 Q2 | -4.9% | 19% | -11.4% | -6.8% | 0.19 | +203.6% |
| Period | P/B |
|---|---|
| 2026 Q1 | 4.10 |
| 2025 Q4 | 5.78 |
| 2025 Q3 | 5.68 |
| 2025 Q2 | 5.14 |
| 2025 Q1 | 4.86 |
| 2024 Q4 | 4.91 |
| 2024 Q3 | 4.20 |
| 2024 Q2 | 3.39 |
What is the GENIL stock price?
The current price of GENIL is 9.24 TRY. (2026-07-17)
What is the GENIL E/P ratio?
The annual (TTM) E/P ratio of GENIL is 0.0181. Market cap: 48.2B TRY.
What sector is GENIL in?
GENIL (GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.) operates in the Toptan Ticaret sector.
What is the GENIL P/B ratio?
The P/B (Price-to-Book) ratio of GENIL is 4.10.
GENIL Stock Analysis — Borsa Istanbul
This page provides a comprehensive analysis of GENIL (GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.), a company listed on Borsa Istanbul in the Toptan Ticaret sector. The current share price, daily percentage change, and trading volume are updated at the end of each trading session using official BIST data.
Momentum and Technical Indicators
Short-term and medium-term momentum indicators for GENIL are calculated using 21-day and 63-day return windows. The 21-day Sortino ratio measures risk-adjusted performance by penalizing only downside volatility, providing a cleaner signal than standard deviation-based metrics. Annualized volatility and 252-day (one-year) momentum are also displayed to help investors assess both trend strength and risk characteristics of GENIL relative to its sector peers.
Fundamental Metrics
Key valuation ratios include the Earnings-to-Price (E/P) ratio calculated on both quarterly and trailing twelve-month (TTM) bases, the Price-to-Book (P/B) ratio derived from the most recent balance sheet equity, and market capitalization. Financial health indicators such as ROE (Return on Equity), ROA (Return on Assets), net profit margin, gross margin, and debt-to-equity ratio are sourced from the latest disclosed quarterly financial statements filed with KAP (Public Disclosure Platform).
Sector Comparison
GENIL is compared against other stocks in the Toptan Ticaret sector across momentum, valuation, and profitability dimensions. The sector comparison table ranks GENIL against its peers using percentile scores, making it easy to identify whether the stock is relatively cheap (high E/P), growing faster (high momentum), or more profitable (high ROE) compared to the sector median. All data is refreshed daily and financial ratios are updated each quarter after earnings disclosures.